For instance, in colorectal cancer (CRC), up-regulation of MAP3K1, MAP3K4, MAP3K7, and MAP3K8 has been associated with tumor progression, activation of oncogenic signaling pathways, and poor prognosis [15, 17], similar to findings in GC. This evidence concerns the gene MAP3K1 and colorectal cancer.